Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study.

Gonzalez CD, Hansen C, Clarke JT.

J Am Acad Dermatol. 2019 Sep;81(3):859-860. doi: 10.1016/j.jaad.2019.04.068. Epub 2019 May 11. No abstract available.

PMID:
31085265
2.

Combined malonic and methylmalonic aciduria due to ACSF3 mutations: Benign clinical course in an unselected cohort.

Levtova A, Waters PJ, Buhas D, Lévesque S, Auray-Blais C, Clarke JTR, Laframboise R, Maranda B, Mitchell GA, Brunel-Guitton C, Braverman NE.

J Inherit Metab Dis. 2019 Jan;42(1):107-116. doi: 10.1002/jimd.12032.

PMID:
30740739
3.

Acute localized exanthematous pustulosis (ALEP) caused by lamotrigine.

Hopkins Z, Frigerio A, Clarke JT.

JAAD Case Rep. 2018 Jul 25;4(7):645-647. doi: 10.1016/j.jdcr.2018.03.017. eCollection 2018 Aug. No abstract available.

4.

Progressive Annular Plaques in a Toddler.

Hyde K, Cope A, Clarke JT.

JAMA Dermatol. 2018 Jan 1;154(1):97-98. doi: 10.1001/jamadermatol.2017.2951. No abstract available.

PMID:
28832879
5.

Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study.

Tran C, Patel J, Stacy H, Mamak EG, Faghfoury H, Raiman J, Clarke JTR, Blaser S, Mercimek-Mahmutoglu S.

Eur J Paediatr Neurol. 2017 Jul;21(4):600-609. doi: 10.1016/j.ejpn.2017.02.006. Epub 2017 Feb 21.

PMID:
28274546
6.

Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy/PLA2G6 by biometric analysis.

Al-Maawali A, Yoon G, Feigenbaum AS, Halliday WC, Clarke JT, Branson HM, Banwell BL, Chitayat D, Blaser SI.

Neuroradiology. 2016 Oct;58(10):1035-1042. Epub 2016 Aug 11.

PMID:
27516098
7.

Methylmalonyl-coA epimerase deficiency: A new case, with an acute metabolic presentation and an intronic splicing mutation in the MCEE gene.

Waters PJ, Thuriot F, Clarke JT, Gravel S, Watkins D, Rosenblatt DS, Lévesque S.

Mol Genet Metab Rep. 2016 Sep 24;9:19-24. eCollection 2016 Dec.

8.

Little evidence for enhanced phenotypic evolution in early teleosts relative to their living fossil sister group.

Clarke JT, Lloyd GT, Friedman M.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11531-11536. Epub 2016 Sep 26.

9.

UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.

Auray-Blais C, Lavoie P, Tomatsu S, Valayannopoulos V, Mitchell JJ, Raiman J, Beaudoin M, Maranda B, Clarke JT.

Anal Chim Acta. 2016 Sep 14;936:139-48. doi: 10.1016/j.aca.2016.06.054. Epub 2016 Jul 2.

PMID:
27566349
10.

Esophagitis Dissecans Superficialis Endoscopically Induced in a Patient With Pemphigus Vulgaris and Gastrointestinal Complaints.

Braunberger T, Hawkes JE, Clarke JT, Boynton KK, Leiferman KM.

JAMA Dermatol. 2016 Aug 1;152(8):948-50. doi: 10.1001/jamadermatol.2016.1007. No abstract available.

PMID:
27144817
11.

Painful Perianal Papules in a Middle-Aged Woman.

Gonzalez CD, Chung CG, Clarke JT.

JAMA Dermatol. 2016 Jul 1;152(7):833-5. doi: 10.1001/jamadermatol.2016.0143. No abstract available. Erratum in: JAMA Dermatol. 2016 May 1;152(5):592.

PMID:
27007404
12.

Discovery of diffuse aurora on Mars.

Schneider NM, Deighan JI, Jain SK, Stiepen A, Stewart AI, Larson D, Mitchell DL, Mazelle C, Lee CO, Lillis RJ, Evans JS, Brain D, Stevens MH, McClintock WE, Chaffin MS, Crismani M, Holsclaw GM, Lefevre F, Lo DY, Clarke JT, Montmessin F, Jakosky BM.

Science. 2015 Nov 6;350(6261):aad0313. doi: 10.1126/science.aad0313.

13.

Annular keratotic papules on the extremities.

Bennett JA, Clarke JT, Ioffreda MD.

J Am Acad Dermatol. 2015 Nov;73(5):891-3. doi: 10.1016/j.jaad.2013.03.010. No abstract available.

PMID:
26475551
14.

Dynamic auroral storms on Saturn as observed by the Hubble Space Telescope.

Nichols JD, Badman SV, Baines KH, Brown RH, Bunce EJ, Clarke JT, Cowley SW, Crary FJ, Dougherty MK, Gérard JC, Grocott A, Grodent D, Kurth WS, Melin H, Mitchell DG, Pryor WR, Stallard TS.

Geophys Res Lett. 2014 May 28;41(10):3323-3330. Epub 2014 May 20.

15.

Individualizing patient education for greater patient satisfaction.

Alagheband SJ, Miller JJ, Clarke JT.

Cutis. 2015 May;95(5):291-2.

PMID:
26057507
16.

Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice.

Butler B, Gamble-George J, Prins P, North A, Clarke JT, Khoshbouei H.

J Addict Prev. 2014;2(2). pii: 6.

17.

Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms.

Garin I, Elli FM, Linglart A, Silve C, de Sanctis L, Bordogna P, Pereda A, Clarke JT, Kannengiesser C, Coutant R, Tenebaum-Rakover Y, Admoni O, de Nanclares GP, Mantovani G.

J Clin Endocrinol Metab. 2015 Apr;100(4):E681-7. doi: 10.1210/jc.2014-3098. Epub 2015 Jan 16.

18.

JAAD grand rounds. A patient with cardiovascular disease and widespread scaly plaques.

Dimaio C, Clarke JT.

J Am Acad Dermatol. 2015 Feb;72(2):372-4. doi: 10.1016/j.jaad.2012.11.035. No abstract available.

PMID:
25592358
19.

Toward a functional definition of a "rare disease" for regulatory authorities and funding agencies.

Clarke JT, Coyle D, Evans G, Martin J, Winquist E.

Value Health. 2014 Dec;17(8):757-61. doi: 10.1016/j.jval.2014.08.2672. Epub 2014 Oct 18.

20.

Reply: Injectable products considered "samples".

Lam C, Crites JS, Clarke JT, Miller JJ, Kirby JS.

J Am Acad Dermatol. 2015 Jan;72(1):198-9. doi: 10.1016/j.jaad.2014.09.009. No abstract available.

PMID:
25497929
21.

Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.

Auray-Blais C, Blais CM, Ramaswami U, Boutin M, Germain DP, Dyack S, Bodamer O, Pintos-Morell G, Clarke JT, Bichet DG, Warnock DG, Echevarria L, West ML, Lavoie P.

Clin Chim Acta. 2015 Jan 1;438:195-204. doi: 10.1016/j.cca.2014.08.002. Epub 2014 Aug 19.

PMID:
25149322
22.

The use of donated products to train residents to perform injectable cosmetic procedures.

Lam C, Crites JS, Clarke JT, Miller JJ, Kirby JS.

J Am Acad Dermatol. 2014 Aug;71(2):382-5. doi: 10.1016/j.jaad.2014.04.059. No abstract available.

PMID:
25037782
23.

Application of a policy framework for the public funding of drugs for rare diseases.

Winquist E, Coyle D, Clarke JT, Evans GA, Seager C, Chan W, Martin J.

J Gen Intern Med. 2014 Aug;29 Suppl 3:S774-9. doi: 10.1007/s11606-014-2885-y.

24.

Mucocutaneous granulomatous disease in a patient with Hermansky-Pudlak syndrome.

Salvaggio HL, Graeber KE, Clarke LE, Schlosser BJ, Orlow SJ, Clarke JT.

JAMA Dermatol. 2014 Oct;150(10):1083-7. doi: 10.1001/jamadermatol.2014.147. Review.

PMID:
24989352
25.

Outcomes of patients treated through the Canadian Fabry disease initiative.

Sirrs SM, Bichet DG, Casey R, Clarke JT, Lemoine K, Doucette S, West ML; CFDI investigators.

Mol Genet Metab. 2014 Apr;111(4):499-506. doi: 10.1016/j.ymgme.2014.01.014. Epub 2014 Feb 2.

PMID:
24534763
26.

Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa.

Schiffmann R, Ries M, Blankenship D, Nicholls K, Mehta A, Clarke JT, Steiner RD, Beck M, Barshop BA, Rhead W, West M, Martin R, Amato D, Nair N, Huertas P.

Genet Med. 2013 Dec;15(12):983-9. doi: 10.1038/gim.2013.56. Epub 2013 May 16.

PMID:
23680766
27.

Tumor necrosis factor inhibition and glucose homeostasis.

Larsen AJ, Clarke JT.

J Am Acad Dermatol. 2013 Jun;68(6):e182-3. doi: 10.1016/j.jaad.2012.10.052. No abstract available.

PMID:
23680212
28.

JAAD Grand Rounds quiz. A rapidly growing tumor on the scalp.

Taylor KA, Clarke LE, Clarke JT.

J Am Acad Dermatol. 2012 Nov;67(5):1091-2. doi: 10.1016/j.jaad.2012.01.043. No abstract available.

PMID:
23062902
29.

An evaluation framework for funding drugs for rare diseases.

Winquist E, Bell CM, Clarke JT, Evans G, Martin J, Sabharwal M, Gadhok A, Stevenson H, Coyle D.

Value Health. 2012 Sep-Oct;15(6):982-6. doi: 10.1016/j.jval.2012.06.009.

30.

Antimalarial myopathy in amyopathic dermatomyositis.

Foulke G, Baccon J, Marks JG, Clarke JT.

Arch Dermatol. 2012 Sep;148(9):1100-1. doi: 10.1001/archdermatol.2012.1711. No abstract available.

PMID:
22986884
31.

Erythropoietic protoporphyria: spectrum of three cases.

Bertrand J, Clarke JT, Hanna D.

J Cutan Med Surg. 2012 Sep-Oct;16(5):311-6.

PMID:
22971305
32.

Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.

Gruner C, Verocai F, Carasso S, Vannan MA, Jamorski M, Clarke JT, Care M, Iwanochko RM, Rakowski H.

Echocardiography. 2012 Aug;29(7):810-7. doi: 10.1111/j.1540-8175.2012.01704.x. Epub 2012 Apr 13.

PMID:
22497597
33.

Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics.

Auray-Blais C, Boutin M, Gagnon R, Dupont FO, Lavoie P, Clarke JT.

Anal Chem. 2012 Mar 20;84(6):2745-53. doi: 10.1021/ac203433e. Epub 2012 Feb 28.

PMID:
22309310
34.

An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.

Auray-Blais C, Lavoie P, Zhang H, Gagnon R, Clarke JT, Maranda B, Young SP, An Y, Millington DS.

Clin Chim Acta. 2012 Apr 11;413(7-8):771-8. doi: 10.1016/j.cca.2012.01.012. Epub 2012 Jan 20.

PMID:
22285314
35.

Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.

Goreshi R, Okawa J, Rose M, Feng R, Lee LA, Hansen CB, Bangert CA, Connolly MK, Davis MD, Callen JP, Fett NM, Fakharzadeh SS, Clarke JT, Werth VP.

J Invest Dermatol. 2012 Apr;132(4):1117-24. doi: 10.1038/jid.2011.440. Epub 2012 Jan 5.

36.

Source document verification in the Mucopolysaccharidosis Type I Registry.

Verhulst K, Artiles-Carloni L, Beck M, Clarke JT, Neto JC, Cox GF, Fernhoff PM, Guffon N, Kong Y, Martins AM, Tylki-Szymanska A, Whitley CB, Wijburg FA, Wraith EJ, Koepper CM.

Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):749-752. doi: 10.1002/pds.2200. Epub 2011 Dec 14.

PMID:
22170853
37.

Impact of measures to enhance the value of observational surveys in rare diseases: the Fabry Outcome Survey (FOS).

Clarke JT, Giugliani R, Sunder-Plassmann G, Elliott PM, Pintos-Morell G, Hernberg-Ståhl E, Malmenäs M, Beck M; FOS Investigators.

Value Health. 2011 Sep-Oct;14(6):862-6. doi: 10.1016/j.jval.2011.05.002. Epub 2011 Jun 23.

38.

Establishing a time-scale for plant evolution.

Clarke JT, Warnock RC, Donoghue PC.

New Phytol. 2011 Oct;192(1):266-301. doi: 10.1111/j.1469-8137.2011.03794.x. Epub 2011 Jul 6.

39.

X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism.

Wang Y, Busin R, Reeves C, Bezman L, Raymond G, Toomer CJ, Watkins PA, Snowden A, Moser A, Naidu S, Bibat G, Hewson S, Tam K, Clarke JT, Charnas L, Stetten G, Karczeski B, Cutting G, Steinberg S.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):160-6. doi: 10.1016/j.ymgme.2011.05.016. Epub 2011 Jun 22.

PMID:
21700483
40.
41.

Dermal dendritic cells in psoriasis, nummular dermatitis, and normal-appearing skin.

Clarke LE, Helm KF, Hennessy J, Bruggeman RD, Clarke JT.

J Am Acad Dermatol. 2012 Jan;66(1):98-105. doi: 10.1016/j.jaad.2010.12.001. Epub 2011 Jun 12.

PMID:
21669473
42.

The auroral footprint of Enceladus on Saturn.

Pryor WR, Rymer AM, Mitchell DG, Hill TW, Young DT, Saur J, Jones GH, Jacobsen S, Cowley SW, Mauk BH, Coates AJ, Gustin J, Grodent D, Gérard JC, Lamy L, Nichols JD, Krimigis SM, Esposito LW, Dougherty MK, Jouchoux AJ, Stewart AI, McClintock WE, Holsclaw GM, Ajello JM, Colwell JE, Hendrix AR, Crary FJ, Clarke JT, Zhou X.

Nature. 2011 Apr 21;472(7343):331-3. doi: 10.1038/nature09928.

PMID:
21512570
43.

JAAD Grand Rounds quiz. A slow-growing nodular plaque.

Finney RL Jr, Clarke LE, Clarke JT.

J Am Acad Dermatol. 2011 Jan;64(1):212-4. doi: 10.1016/j.jaad.2010.07.041. No abstract available.

PMID:
21167423
44.

Hunter disease eClinic: interactive, computer-assisted, problem-based approach to independent learning about a rare genetic disease.

Al-Jasmi F, Moldovan L, Clarke JT.

BMC Med Educ. 2010 Oct 25;10:72. doi: 10.1186/1472-6920-10-72.

45.

Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.

Auray-Blais C, Bhérer P, Gagnon R, Young SP, Zhang HH, An Y, Clarke JT, Millington DS.

Mol Genet Metab. 2011 Jan;102(1):49-56. doi: 10.1016/j.ymgme.2010.09.003. Epub 2010 Sep 17.

PMID:
20934363
46.

An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants).

Clarke JT, Mahuran DJ, Sathe S, Kolodny EH, Rigat BA, Raiman JA, Tropak MB.

Mol Genet Metab. 2011 Jan;102(1):6-12. doi: 10.1016/j.ymgme.2010.09.004. Epub 2010 Sep 17.

47.

Case report: Long-term outcome post-heart transplantation in a woman with Fabry's disease.

Verocai F, Clarke JT, Iwanochko RM.

J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S385-7. doi: 10.1007/s10545-010-9194-3. Epub 2010 Sep 18.

PMID:
20852936
48.

How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?

Auray-Blais C, Ntwari A, Clarke JT, Warnock DG, Oliveira JP, Young SP, Millington DS, Bichet DG, Sirrs S, West ML, Casey R, Hwu WL, Keutzer JM, Zhang XK, Gagnon R.

Clin Chim Acta. 2010 Dec 14;411(23-24):1906-14. doi: 10.1016/j.cca.2010.07.038. Epub 2010 Aug 14.

PMID:
20716442
49.

Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.

Thomas JA, Beck M, Clarke JT, Cox GF.

J Inherit Metab Dis. 2010 Aug;33(4):421-7. doi: 10.1007/s10545-010-9113-7. Epub 2010 Jun 2.

50.

JAAD Grand Rounds quiz. An infant with a pruritic plantar eruption.

Marszalek RM, Clarke JT.

J Am Acad Dermatol. 2010 May;62(5):906-8. doi: 10.1016/j.jaad.2010.01.039. No abstract available.

PMID:
20398830

Supplemental Content

Loading ...
Support Center